Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection
Clinical trial NCT04513158 · TERMINATED
Trial details
- NCT number
- NCT04513158
- Sponsor
- Joseph M. Flynn, D.O., MPH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-14
- Primary completion
- 2021-04-28
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.